Naresh Gupta
Overview
Explore the profile of Naresh Gupta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
864
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gupta N, Dutta A, Ahmed B, Ross C, S C, Dolan G, et al.
Cureus
. 2024 May;
16(5):c172.
PMID: 38726357
[This corrects the article DOI: 10.7759/cureus.58941.].
2.
Gupta N, Dutta A, Ahmed B, Ross C, S C, Dolan G, et al.
Cureus
. 2024 May;
16(4):e58941.
PMID: 38725780
Hemophilia A (HA) is a genetic disorder of hemostasis associated with a deficiency or reduced activity of clotting factor VIII (FVIII). This disorder remains unacceptably underdiagnosed in India. Early diagnosis...
3.
Ninawe A, Guru S, Yadav P, Masroor M, Samadhiya A, Bhutani N, et al.
ACS Omega
. 2021 Mar;
6(11):7711-7718.
PMID: 33778281
MicroRNA miR-486-5p has been reported as a potential biomarker for diagnosis, prognosis, and as a therapeutic target in various cancers. In this study, we analyzed alterations in the expression of...
4.
Nusrath S, Nair A, Dasu S, Subramanyeshwar Rao T, Raju K, Rayani B, et al.
Indian J Surg Oncol
. 2020 Oct;
11(3):378-386.
PMID: 33013114
The optimal duration of prophylactic antimicrobial usage in clean-contaminated elective oncological surgeries is not clear. This single-center randomized trial evaluated the effectiveness of single-dose antimicrobial prophylaxis in clean-contaminated surgeries for...
5.
Assessment of Quality of Life in Severe Hemophilia Using Generic and Hemophilia Specific Instruments
Singh J, Gupta N, Garg S
J Assoc Physicians India
. 2020 Jan;
68(1):101.
PMID: 31979942
No abstract available.
6.
Gupta N, Benbouzid A, Belhani M, El Andaloussi M, Maani K, Wali Y, et al.
TH Open
. 2019 Jul;
3(2):e190-e199.
PMID: 31259302
Optimizing hemophilia care remains challenging in developing countries. Burden-of-disease studies are important to develop strategies for improving hemophilia care. The HAEMOcare study evaluated the factors contributing to hemophilia-related orthopedic disease...
7.
Dhar J, Chhabra G, Khandelwal L, Batra A, Gupta N
J Coll Physicians Surg Pak
. 2019 Jan;
29(1):78-80.
PMID: 30630577
Chronic myeloid leukemia (CML) is a chronic myeloproliferative disorder that usually presents with high white blood cell counts and massive splenomegaly. Priapism is a rare manifestation of CML and is...
8.
Thoyyib M, Garg S, Gupta N, Aggarwal S, Pandit S
Indian J Endocrinol Metab
. 2018 Aug;
22(4):479-484.
PMID: 30148093
Introduction: A kaleidoscope of coagulation disorders has been reported in patients with thyroid dysfunctions. Globally, these disorders involve both primary and secondary hemostasis and range from subclinical laboratory abnormalities to,...
9.
Mir R, Ah I, Javid J, Zuberi M, Guru S, Mirza M, et al.
World J Oncol
. 2017 Nov;
6(2):321-328.
PMID: 29147425
Background: Mammalian cells contain three functional RAS proto-oncogenes, known as H-RAS, K-RAS, and N-RAS, which encode small GTP-binding proteins in terms of p21s. RAS genes have been elucidated as major...
10.
Guru S, Mir R, Bhat M, Najar I, Zuberi M, Sumi M, et al.
Tumour Biol
. 2017 Oct;
39(10):1010428317713857.
PMID: 29019285
Platelet-derived growth factor receptor has been implicated in many malignant and non-malignant diseases. Platelet-derived growth factor receptor-α is a tyrosine kinase and a side target for imatinib, a revolutionary drug...